deltatrials
Completed PHASE2 NCT00310401

The Effect of Nebulized Albuterol on Donor Oxygenation

Sponsor: California Transplant Donor Network

Conditions Brain Death Organ Donor Pulmonary Edema
Interventions Albuterol Saline
Updated 9 times since 2017 Last updated: Feb 14, 2018 Started: Apr 30, 2007 Primary completion: May 31, 2011 Completion: Jun 30, 2011

This PHASE2 trial investigates Brain Death and Organ Donor and is currently completed. California Transplant Donor Network leads this study, which shows 9 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE2

▶ Show 4 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  2. Apr 2018 — Jun 2018 [monthly]

    Completed PHASE2

  3. Nov 2017 — Apr 2018 [monthly]

    Completed PHASE2

  4. Jan 2017 — Nov 2017 [monthly]

    Completed PHASE2

    First recorded

Apr 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • California Transplant Donor Network
  • University of California, San Francisco
  • Vanderbilt University Medical Center
Data source: Vanderbilt University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Oakland, United States